RxDoctor Payments Data

Shaw Tang, DO

Plastic and Reconstructive Surgery · Tulsa, OKNPI 1578684809

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,550 of the $3,382 with a category attached, or 75.4%. It is spread thinly across 32 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,652 and has fallen 85.6% since, to $238 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OK, where the typical reported total is $3,788.

$3,382in general payments, 2019–2025

Across 114 payments — averaging $29.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$745
  • KCI USA, Inc.$520
  • Stryker$382
  • Smith+Nephew$298
  • Paratek Pharmaceuticals, Inc.$189
  • Medline Industries LP$188
  • plus $1K from 26 others

What the payments were for

  • Travel & lodging$80524%
  • Food & beverage$2,55075%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,382 in reported general payments places this provider in the 45th percentile of 22 plastic and reconstructive surgery providers in Oklahoma.

See all plastic and reconstructive surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$69,418
Medicare patients
81
Services billed
734

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate15$150
Doxycycline Hyclate13$122

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →